56 related articles for article (PubMed ID: 3290935)
1. A pilot study of serotonergic system responsivity in Alzheimer's disease.
Lawlor BA; Mellow AM; Sunderland T; Hill JL; Murphy DL
Psychopharmacol Bull; 1988; 24(1):127-9. PubMed ID: 3290935
[No Abstract] [Full Text] [Related]
2. Phosphatidylserine in the treatment of Alzheimer's disease: results of a multicenter study.
Amaducci L
Psychopharmacol Bull; 1988; 24(1):130-4. PubMed ID: 3290936
[No Abstract] [Full Text] [Related]
3. Effects of 4-aminopyridine in elderly patients with Alzheimer's disease.
Wesseling H; Agoston S; Van Dam GB; Pasma J; DeWit DJ; Havinga H
N Engl J Med; 1984 Apr; 310(15):988-9. PubMed ID: 6366565
[No Abstract] [Full Text] [Related]
4. Caregiver time use: an outcome measure in clinical trial research on Alzheimer's disease.
Clipp EC; Moore MJ
Clin Pharmacol Ther; 1995 Aug; 58(2):228-36. PubMed ID: 7648773
[TBL] [Abstract][Full Text] [Related]
5. Low- and high-dose naloxone in dementia of the Alzheimer type.
Tariot PN; Sunderland T; Weingartner H; Murphy DL; Cohen MR; Cohen RM
Psychopharmacol Bull; 1985; 21(3):680-2. PubMed ID: 3898183
[No Abstract] [Full Text] [Related]
6. A neuropsychological test battery for use in Alzheimer disease clinical trials.
Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
Antuono PG
Arch Intern Med; 1995 Sep; 155(16):1766-72. PubMed ID: 7654110
[TBL] [Abstract][Full Text] [Related]
8. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
[TBL] [Abstract][Full Text] [Related]
9. Choline in Alzheimer's disease.
Renvoize EB; Jerram T
N Engl J Med; 1979 Aug; 301(6):330. PubMed ID: 377082
[No Abstract] [Full Text] [Related]
10. [The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
Acierno G
Clin Ter; 1983 Apr; 105(2):135-45. PubMed ID: 6345054
[No Abstract] [Full Text] [Related]
11. NGF and the treatment of Alzheimer's disease.
Olson L
Exp Neurol; 1993 Nov; 124(1):5-15. PubMed ID: 8282080
[TBL] [Abstract][Full Text] [Related]
12. Cognitive and behavioral sensitivity to scopolamine in Alzheimer patients and controls.
Sunderland T; Tariot PN; Mueller EA; Murphy DL; Weingartner H; Cohen RM
Psychopharmacol Bull; 1985; 21(3):676-9. PubMed ID: 3898182
[No Abstract] [Full Text] [Related]
13. Evaluation of an analogue of somatostatin (L363,586) in Alzheimer's disease.
Cutler NR; Haxby JV; Narang PK; May C; Burg C; Reines SA
N Engl J Med; 1985 Mar; 312(11):725. PubMed ID: 2858052
[No Abstract] [Full Text] [Related]
14. A double-blind placebo controlled study of cinnarizine in the prophylaxis of seasickness.
Hargreaves J
Practitioner; 1980 May; 224(1343):547-50. PubMed ID: 6999486
[No Abstract] [Full Text] [Related]
15. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.
Ritchie CW; Bush AI; Mackinnon A; Macfarlane S; Mastwyk M; MacGregor L; Kiers L; Cherny R; Li QX; Tammer A; Carrington D; Mavros C; Volitakis I; Xilinas M; Ames D; Davis S; Beyreuther K; Tanzi RE; Masters CL
Arch Neurol; 2003 Dec; 60(12):1685-91. PubMed ID: 14676042
[TBL] [Abstract][Full Text] [Related]
16. Behavioral effects of trazodone in Alzheimer's disease.
Lebert F; Pasquier F; Petit H
J Clin Psychiatry; 1994 Dec; 55(12):536-8. PubMed ID: 7814348
[TBL] [Abstract][Full Text] [Related]
17. Neotrofin clinical trials show promise.
Am J Alzheimers Dis Other Demen; 2001; 16(1):8-9. PubMed ID: 11416953
[No Abstract] [Full Text] [Related]
18. [Treatment of hypertension with alpha blockade or ACE inhibition. Multicenter double-blind study of urapidil versus captopril].
Rosenthal J; Haerlin R
Fortschr Med; 1986 Oct; 104(40):763-6. PubMed ID: 3536700
[No Abstract] [Full Text] [Related]
19. The Alzheimer's Disease Cooperative Study in 2004.
Thal LJ
Alzheimer Dis Assoc Disord; 2004; 18(4):183-5. PubMed ID: 15592126
[No Abstract] [Full Text] [Related]
20. Donepezil for Alzheimer's disease.
Sparano N
J Fam Pract; 1998 May; 46(5):356. PubMed ID: 9597987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
